A Phase II Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Resectable Hepatic-Limited Metastatic Colorectal Cancer HCRN: GI16-288
Phase of Trial: Phase II
Latest Information Update: 02 Nov 2018
At a glance
- Drugs CV 301 (Primary) ; Nivolumab (Primary) ; Fluorouracil; Folic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- 11 Jul 2018 According to a Bavarian Nordic media release, first patient has been dosed in this study.
- 11 Jul 2018 Status changed from not yet recruiting to recruiting, according to a Bavarian Nordic media release.
- 14 Mar 2018 New trial record